YAKHAK HOEJI (약학회지)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

The lyophilization and stability of Salmonella typhi Ty21a

Salmonella thphi Ty21a의 동결 건조와 안정성

  • Published : 1999.12.01
Download PDF
⟨ Previous Next ⟩

Abstract

Salmonella typhi Ty21a is an attenuated strain of S. typhimurium and used for oral typhoid vaccine. In an attempt to increase the stability of Ty21a manufacturing typhoid vaccine, we studied about the stability of freeze-dried Th21a including additives at various temperature conditions. In order to investigate the freeze-drying rate of Ty21a according to various absorbance, we lyophilized Ty21a by using 8% sucrose as a stabilizer. The optimal freeze-drying rate of Ty21a was appeared when OD (optical density) value of the growth was between 2.5 and 3.0. To investigate the stability of Ty21a at various temperature, the viability was measured after storaging the freeze-dried Ty21a at the room temperature, cold and freezing condition for 1 week. The viability of Ty21a in cold and freezing storage condition was 5 times more stable than in room temperature. To search the most stable additives for the freeze-dried Ty21a, the viability of Ty21a including additives at the various storage condition was estimated. Mannitol and loctose were the most stable additives. Theses results suggest that the OD value of Ty21a growth, low temperature, mannitol and lactose are important factors for the optimal freeze-drying rate, the stable storage and the most stable additives, respectively.

Keywords

References

  1. Clin. North. Am. v.21 Bacterial enteric infections and vaccine development Holmgren J.;Svennerholm A. M.
  2. Med. J. v.40 Enteric vaccines Edelman R.;Levine M. M.
  3. Rev. Infect. Dis. v.11 Progress in vaccines against typhoid fever Levin M. M.;Ferreccio C.;Black R. E.;Tacket C. O.;Germanier R
  4. Lancet. v.336 Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in ran-domised controlled field trial Myron M. L.;Catterine F.;Stanley C.;Edith O.
  5. Infect. Immun. v.57 Construction and Characterization of Vi-Positive Variant of the S. typhi Live Oral Vaccine Strain Ty21a S. J. CRYZ;J. R.;E. FURER;S. S. BARON;K. F. NOON;F. A. RUBIN;D. J. KOPECKO
  6. Lancet. v.338 Oral typhoid vaccine Ty21a Bruce D. F.
  7. Dev. Biol. Stand. v.53 Immunogenicity of Ty21a attenuated "Salmonella typhi" given with sodium bicarbonate or in enteric-coated capsules Black R.;Levin M. M.;Young C.;Rooney J.;Levine S.;Clements ML.;O'Donnell S.;Hugues T.;Germanier R.
  8. Arch. Biochem. Biophys. v.358 Effecs of Drying Methods and Additives on Structure and Fuction of Actin: Mechanisms of Dehydration-Induced Damage and Its Inhibition S. Dean Allison;Theodore, W. R.;Mark, C. M.;Kim, M.;Ashley D.;John F. C.
  9. A Study on the Drying Characteristics of Fursulthiamine Hydrochloride of Freeze-Drying 강호식
  10. Arch. Biochem. Biophys. v.303 Separation of freezing-and drying-induced denaturation of lyophilized proteins using stress-specific stabilization II. Structural studies using infrared spectroscopy Prestrelski S. J.;Arakawa T.;Carpenter J F.
  11. Arch. Biochem. Biophys. v.365 Hydrogen bonding between sugar and protein is responsible for inhibition of dehydration-induced protein unfolding Allison S. D.;Chang B.;Randoph T. W.;Carpenter J. F.
  12. 종합미생물학 미생물학분과회(저)
  13. Dev. Biol. Stand. v.87 Factors influencing the stability of live oral attenuated bacterial vaccines Crzy S. J.;Pasteris O.;Varallyay S. J.;Furer E.
  14. Pharm. Res v.13 Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in bio-degradable microspheres Cleland J. L.;Jones A. J.
  15. J. Pharm. Sci. v.87 Effects of excipients on the stability and structure of lyophilized recombinant human growth hormone Costantino H. R.;Carrasquillo K. G.;Cordero R. A.;Mumenthaler M.;Hsu C. C.;Griebenow K.
  16. J. Pharm. Sci. v.85 Effects of reducing sugars on the chemical stability of human relaxin in the lyophilized state Li S.;Patapoff T.W.;Overcashier D.;Hsu C.;Nguyen T.H.;Borchardt R. T.